<DOC>
	<DOCNO>NCT02000063</DOCNO>
	<brief_summary>A single long-term follow assessment establish multi-centre , prospective longitudinal cohort study patient clinical , psychosocial , immunovirological outcome 4 8 year previous treatment recently acquire hepatitis C virus infection .</brief_summary>
	<brief_title>Australian Trial Acute Hepatitis C Recall Study</brief_title>
	<detailed_description>The study aim : 1 . To evaluate effect successful prior treatment spontaneous clearance recently acquire HCV infection long-term quality life , social functioning , inject behaviour , mental health liver health . 2 . To assess incidence HCV re-infection follow prior treatment induce clearance spontaneous clearance recently acquire chronic HCV infection . 3 . To determine predictor HCV re-infection follow recently acquire HCV infection treatment . 4 . To determine frequency predictor new mixed superinfection ATAHC subject persistent viraemia . 5 . To add tissue repository serum PBMCs well-characterised patient treat recently acquire HCV infection allow future examination role variable may potentially impact prognosis outcomes early HCV treatment .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Previous enrolment Australian Trial Acute Hepatitis C Virus Infection ( ATAHC ) Study . Provision write , informed consent . In opinion investigator patient able provide inform consent . Inability unwillingness comply study collection requirement .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>acute</keyword>
	<keyword>early chronic</keyword>
</DOC>